CDKN2A and breast carcinoma: Most of these associations are in line with earlier IHC studies examining 10, 60, 82 and 314 breast tumors that had already suggested associations between p16 overexpression and adverse features of breast cancer such as high grade [7–10], nodal stage [10] and poor patient prognosis [9, 10].